On September 7, CHINA TAIPING fell 3.09% in regular trading, trading at 21.98 HKD/share, with turnover of HKD 65.43 million.

On the news front, the Ministry of Finance announced on September 6 a planned capital injection of 7 billion yuan into China Taiping Insurance Group, forming part of a broader 360 billion yuan recapitalization program targeting eight central financial enterprises. The official statement noted the injection aims to enhance risk resilience and promote balanced, sound development of key metrics including solvency adequacy ratios. The market interpreted this language as an implicit acknowledgment that the company's solvency adequacy ratio is under pressure. Notably, the scale of this injection significantly exceeds the approximately 2.5 billion yuan in cumulative capital injections from the Ministry over the prior three years. Alongside CHINA TAIPING, three other state-owned insurers — China Life, PICC, and Sinosure — received a combined 67 billion yuan in planned injections.

For context, the company reported strong first-half results in late August, with attributable profit surging 90.3% year-on-year to HKD 12.873 billion and total investment income rising 120.5%. However, analysts had previously flagged declining solvency ratios in its life insurance and pension segments, likely driven by increased equity asset allocation.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)